|
|||||
       |
(National Renewable Energy Laboratory) Martin LaMonica reports today in CNet that the U.S. Patent and Trademark Office’s (USPTO’s) accelerated review program for green technology patent applications has not had the anticipated overwhelming response. In December 2009, USPTO announced it would bump up to the front of the queue for appraisal patent petitions for . . . → Read More: Slow Uptake for Green Tech Patent Fast Track CEM Corporation, a maker of microwave lab instruments in Matthews, North Carolina, says the European Patent Office now allows the company’s patent claims for its process of microwave peptide synthesis. Peptides are amino acid compounds found in proteins. The company says allowance covers the process of using microwave energy to accelerate two key steps in . . . → Read More: Patent Allowance Granted for Microwave Peptide Synthesis University of Oklahoma (OU) in Norman and the oil company ConocoPhillips will establish a new program to conduct research on biocorrosion affecting petroleum pipelines, storage facilities, tankers, and refineries. The new Biocorrosion Center will be part of OU’s Institute for Energy and Environment. Researchers in the program will explore scientific issues to better understand and . . . → Read More: University, Oil Company Partner on Infrastructure Corrosion The Alzheimer’s Drug Discovery Foundation (ADDF) has awarded a grant of $240,000 to AgeneBio Inc. of Indianapolis, Indiana to develop a new class of small molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer’s disease. About 15 percent of aMCI patients progress to Alzheimer’s disease. . . . → Read More: Foundation Funds R&D for Alzheimer’s Precursor Treatment (Agricultural Research Service, USDA) Wasps, hornets, and yellow jackets will spoil any summer barbeque or picnic, but they also pose a serious threat to agriculture field workers, particularly at harvest time. Research by scientists with the Agricultural Research Service (ARS), a division of the U.S. Department of Agriculture (USDA), has led to development . . . → Read More: USDA Research Leads to Commercial Stinging Insect Trap (Yale School of Medicine/Wikimedia Commons) Cardioxyl Pharmaceuticals Inc. in Chapel Hill, North Carolina, today announced the start of clinical trial of its lead drug candidate, CXL-1020, for the treatment of acute decompensated heart failure (ADHF). The trial will help define proper dosing for the drug. Cardioxyl’s placebo-controlled phase 2-a trial will take place . . . → Read More: Clinical Trial of Heart Failure Drug Underway Soon The chairman of International Stem Cell Corp. (ISCO) in Oceanside, California, says he does not expect the order on Monday of a judge blocking federal funding of embryonic stem cell research to have negative effects on the company’s therapeutic programs. Judge Royce Lamberth of the U.S. District Court for the District of Columbia issued a . . . → Read More: Stem Cell Company: Court Order Not Applicable to Our Work A two-year clinical study by biotech company FibroGen, located in San Francisco, California, shows surgical implantation of biosynthetic corneas can restore vision and promote nerve regeneration in patients who had corneal damage and significant vision loss. The findings are published in the 25 August issue of Science Translational Medicine. The biosynthetic corneas were made of . . . → Read More: Study Shows Vision Restored with Biosynthetic Corneas The U.K. government’s Intellectual Property Office (IPO) will conduct a research study over the next year to evaluate the role of intellectual property in the nation’s economy. The Parliamentary Under-Secretary for Business, Innovation and Skills Baroness Judith Wilcox announced the project saying, “The research program will improve our understanding of intellectual property and its economic . . . → Read More: U.K. to Study Economic Value of Intellectual Property AdvanSource Biomaterials Corp. in Wilmington, Massachusetts, has received a Notice of Allowance from the U.S. Patent and Trademark Office on its patent for antimicrobial polyurethane resins and derivative products. The notice indicates that AdvanSource Biomaterials is entitled to this patent under the law. The patent covers a drug-free, antimicrobial technology to eradicate Methicillin-resistant Staphylococcus aureus . . . → Read More: Patent Awarded for Antimicrobial Polyurethane Resins |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.